Health Care & Life Sciences » Pharmaceuticals | Mithra Pharmaceuticals

Mithra Pharmaceuticals S.A. | Ownership

Companies that own Mithra Pharmaceuticals S.A.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Ogeo Fund
1,181,700
3.14%
-300,000
100%
11/22/2017
BNP Paribas Asset Management Belgium SA
224,064
0.6%
0
0.09%
07/31/2018
FundQuest Advisor
68,262
0.18%
0
0.72%
07/31/2018
BlackRock Fund Advisors
66,569
0.18%
0
0%
09/06/2018
River & Mercantile Asset Management LLP
55,860
0.15%
55,860
0.05%
09/30/2017
MacKay Shields LLC
33,336
0.09%
33,336
0.01%
06/29/2018
Candriam Belgium SA
30,900
0.08%
-37,574
0.01%
07/31/2018
BlackRock Advisors (UK) Ltd.
24,227
0.06%
0
0%
09/06/2018
The Vanguard Group, Inc.
21,240
0.06%
21,240
0%
07/31/2018
SEI Investments Management Corp.
17,141
0.05%
17,141
0%
06/30/2018

About Mithra Pharmaceuticals

View Profile
Address
Rue Saint-Georges 5
Liege WA 4000
Belgium
Employees -
Website http://www.mithra.com
Updated 07/08/2019
Mithra Pharmaceuticals SA engages in the development, manufacture, and commercialization of proprietary and differentiated drugs and generic products dedicated to female healthcare. It specializes in the following domains of health for women: contraception and fertility, menopause and osteoporosis, gynecological infections, and cancers. The company was founded by Jean-Michel Foidart and François Fornieri on July 8, 1999 and is headquartered in Liège, Belgium.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.